Cancer Genetics, Inc. Partners with ArcherDX to Offer Archer® NGS Assays as a Sequencing Service for Biotech and Pharma

BOULDER, Colo.--(BUSINESS WIRE)--Cancer Genetics, Inc. to become Certified Service Provider of Archer® FusionPlex® NGS assays by ArcherDX to support clinical trials for global biopharma partners